Scorpius Holdings Inc.

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia

Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining

Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal

Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives